Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
mata orozco
(4 results)?
New pyridine-based chalcones and pyrazolines with anticancer, antibacterial, and antiplasmodial activities.
Arch Pharm (Weinheim). 2024 Mar 28:e2400081. doi: 10.1002/ardp.202400081. Online ahead of print.
Arch Pharm (Weinheim). 2024.
PMID: 38548680
Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations.
Infante M, Arranz-Ledo M, Lastra E, Olaverri A, Ferreira R, Orozco M, Hernández L, Martínez N, Durán M.
Infante M, et al. Among authors: orozco m.
Clin Chim Acta. 2024 Jan 1;552:117695. doi: 10.1016/j.cca.2023.117695. Epub 2023 Dec 6.
Clin Chim Acta. 2024.
PMID: 38061684
Item in Clipboard
Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
Infante M, Arranz-Ledo M, Lastra E, Abella LE, Ferreira R, Orozco M, Hernández L, Martínez N, Durán M.
Infante M, et al. Among authors: orozco m.
Int J Mol Sci. 2022 Sep 29;23(19):11499. doi: 10.3390/ijms231911499.
Int J Mol Sci. 2022.
PMID: 36232793
Free PMC article.
Item in Clipboard
Cite
Cite